Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testingBram Verstockt, Marc Ferrante, Sumin Bian et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 74